2014 Q4 Form 10-Q Financial Statement
#000114420414068425 Filed on November 14, 2014
Income Statement
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $1.070M | $745.0K | |
YoY Change | 43.59% | ||
% of Gross Profit | |||
Depreciation & Amortization | -$10.00K | $30.00K | $0.00 |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $2.605M | $1.453M | |
YoY Change | 79.3% | ||
Operating Profit | -$2.605M | ||
YoY Change | |||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$6.495K | ||
YoY Change | |||
Pretax Income | |||
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$2.612M | -$1.456M | |
YoY Change | 79.34% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | |||
COMMON SHARES | |||
Basic Shares Outstanding | 32.17M shares | 32.00M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.590M | $5.010M | $12.57M |
YoY Change | -76.11% | -60.14% | |
Cash & Equivalents | $2.591M | $5.007M | $12.57M |
Short-Term Investments | |||
Other Short-Term Assets | $210.0K | $110.0K | $30.00K |
YoY Change | 162.5% | 266.67% | |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $2.805M | $5.110M | $12.60M |
YoY Change | -74.32% | -59.44% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $340.0K | $360.0K | $30.00K |
YoY Change | 265.36% | 1100.0% | |
Goodwill | $0.00 | ||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $220.0K | $320.0K | |
YoY Change | -31.25% | ||
Total Long-Term Assets | $556.3K | $680.0K | $30.00K |
YoY Change | 36.07% | 2166.67% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $2.805M | $5.110M | $12.60M |
Total Long-Term Assets | $556.3K | $680.0K | $30.00K |
Total Assets | $3.361M | $5.790M | $12.63M |
YoY Change | -70.34% | -54.16% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $271.2K | $210.0K | $260.0K |
YoY Change | -31.66% | -19.23% | |
Accrued Expenses | $802.7K | $764.7K | $240.0K |
YoY Change | 73.68% | 218.65% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $40.00K | $40.00K | |
YoY Change | |||
Total Short-Term Liabilities | $1.118M | $1.021M | $500.0K |
YoY Change | 30.19% | 104.13% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $20.00K | $20.00K | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $20.00K | $20.00K | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.118M | $1.021M | $500.0K |
Total Long-Term Liabilities | $20.00K | $20.00K | $0.00 |
Total Liabilities | $1.134M | $1.043M | $500.0K |
YoY Change | 31.97% | 108.62% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$14.05M | -$11.01M | |
YoY Change | 266.82% | ||
Common Stock | $3.230K | $3.217K | |
YoY Change | 0.94% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.228M | $4.746M | $12.13M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $3.361M | $5.789M | $12.63M |
YoY Change | -70.34% | -54.17% |
Cashflow Statement
Concept | 2014 Q4 | 2014 Q3 | 2013 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.612M | -$1.456M | |
YoY Change | 79.34% | ||
Depreciation, Depletion And Amortization | -$10.00K | $30.00K | $0.00 |
YoY Change | |||
Cash From Operating Activities | -$2.410M | -$1.610M | -$890.0K |
YoY Change | 44.31% | 80.9% | -9000.0% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | -$30.00K | -$30.00K |
YoY Change | -100.0% | 0.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$30.00K | -$30.00K |
YoY Change | -100.0% | 0.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | 13.03M |
YoY Change | -100.0% | -130400.0% | |
NET CHANGE | |||
Cash From Operating Activities | -2.410M | -1.610M | -890.0K |
Cash From Investing Activities | 0.000 | -30.00K | -30.00K |
Cash From Financing Activities | 0.000 | 0.000 | 13.03M |
Net Change In Cash | -2.410M | -1.640M | 12.11M |
YoY Change | 39.31% | -113.54% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.410M | -$1.610M | -$890.0K |
Capital Expenditures | $0.00 | -$30.00K | -$30.00K |
Free Cash Flow | -$2.410M | -$1.580M | -$860.0K |
YoY Change | 49.69% | 83.72% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
858968 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="0"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">[2]</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="0"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">[4]</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.5in" align="justify"><font style="FONT-SIZE: 10pt">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. Cash balances are maintained principally at one major U.S. financial institution and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. At various times throughout the period ended September 30, 2014, the Company’s cash balances exceeded the FDIC insurance limit. The Company has not experienced any losses in such accounts.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
462200 | USD |
CY2014Q3 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
44086 | USD |
CY2013Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
0 | USD |
CY2014Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1020665 | USD |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
858968 | USD |
CY2014Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
22455 | USD |
CY2013Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
0 | USD |
CY2014Q3 | us-gaap |
Liabilities
Liabilities
|
1043120 | USD |
CY2014Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
764748 | USD |
CY2014Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
3217 | USD |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
3200 | USD |
CY2014Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
15749890 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
14302307 | USD |
CY2014Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11007441 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3830719 | USD |
CY2014Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4745666 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10474788 | USD |
CY2014Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5788786 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11333756 | USD |
mtnb |
Stock To Be Issued Upon Exercise
StockToBeIssuedUponExercise
|
17085000 | shares | |
mtnb |
Stock To Be Issued Upon Exercise
StockToBeIssuedUponExercise
|
20665000 | shares | |
CY2013Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
7500000 | shares |
CY2013Q2 | mtnb |
Warrants Issued For Purchase Of Common Stock
WarrantsIssuedForPurchaseOfCommonStock
|
3750000 | shares |
CY2013Q2 | mtnb |
Common Stock To Be Issued Upon Exercise Of Warrants
CommonStockToBeIssuedUponExerciseOfWarrants
|
3750000 | shares |
CY2013Q2 | invest |
Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
|
2.00 | |
CY2013Q2 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
375000 | USD |
CY2013Q2 | mtnb |
Stock And Warrants Issued Price Per Unit
StockAndWarrantsIssuedPricePerUnit
|
0.10 | |
CY2013Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
2400000 | USD |
CY2013Q3 | mtnb |
Placement Agent Cash Fees And Expenses
PlacementAgentCashFeesAndExpenses
|
1950000 | USD |
CY2013Q3 | mtnb |
External Legal Costs
ExternalLegalCosts
|
425000 | USD |
CY2013Q3 | mtnb |
Securities Penalty Payment Description
SecuritiesPenaltyPaymentDescription
|
Holdings shall pay to each holder of registrable securities purchased in 2013 Private Placement an amount in cash equal to half of one percent (0.5%) of such holder’s investment amount on every thirty (30) day anniversary of such failure to maintain the registration statement until such failure was cured; | |
CY2013Q3 | mtnb |
Effectiveness Of Registration Statement Description
EffectivenessOfRegistrationStatementDescription
|
If the Company does not maintain the effectiveness of the registration statement during the Effectiveness Period, subject to certain limitations and the right of the Company to suspend the use of the prospectus for certain periods, Holdings shall pay to each holder of registrable securities purchased in 2013 Private Placement an amount in cash equal to half of one percent (0.5%) of such holders investment amount on every thirty (30) day anniversary of such failure to maintain the registration statement until such failure was cured; | |
CY2014Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
15250000 | shares |
CY2014Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2014Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32167650 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32000000 | shares |
CY2014Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
32167650 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
32000000 | shares |
CY2013Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
8250000 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
|
0.04 | pure |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
288518 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-28298 | USD | |
CY2014Q2 | mtnb |
Sharebased Compensation Arrangement By Sharebased Payment Award Increase Of Shares Offering Date
SharebasedCompensationArrangementBySharebasedPaymentAwardIncreaseOfSharesOfferingDate
|
January 1, 2015 | |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
44384 | USD |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
154140 | USD |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
157076 | USD |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
160014 | USD |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
582797 | USD |
CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1098411 | USD |
CY2014Q3 | us-gaap |
Security Deposit
SecurityDeposit
|
300000 | USD |
CY2013Q4 | us-gaap |
Lessor Leasing Arrangements Operating Leases Term Of Contract
LessorLeasingArrangementsOperatingLeasesTermOfContract
|
P7Y | |
CY2014Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
2072 | USD |
CY2014Q2 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
12723 | USD |
mtnb |
Security Deposits Reduced By Straight Line Basis Description
SecurityDepositsReducedByStraightLineBasisDescription
|
Starting June1, 2015, this deposit can be reduced by $100,000 on an annual basis, down to $50,000, as long as the Company makes timely rental payments. | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1034700 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3261747 | USD | |
CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
745000 | USD |
CY2014Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1069716 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
873888 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3893100 | USD | |
CY2013Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
708084 | USD |
CY2014Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1535617 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
1908588 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
7154847 | USD | |
CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1453084 | USD |
CY2014Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2605333 | USD |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1908588 | USD | |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-7154847 | USD | |
CY2013Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1453084 | USD |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-2605333 | USD |
us-gaap |
Extraordinary Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
ExtraordinaryItemGainOrLossNetOfTaxAttributableToReportingEntity
|
-3202 | USD | |
us-gaap |
Extraordinary Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
ExtraordinaryItemGainOrLossNetOfTaxAttributableToReportingEntity
|
-21876 | USD | |
CY2013Q3 | us-gaap |
Extraordinary Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
ExtraordinaryItemGainOrLossNetOfTaxAttributableToReportingEntity
|
-3259 | USD |
CY2014Q3 | us-gaap |
Extraordinary Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
ExtraordinaryItemGainOrLossNetOfTaxAttributableToReportingEntity
|
-6495 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1911790 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7176723 | USD | |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1456343 | USD |
CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2611828 | USD |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.13 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.22 | ||
CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
CY2014Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.08 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
14895604 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
32020265 | shares | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
14895604 | shares |
CY2014Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
32060796 | shares |
us-gaap |
Depreciation
Depreciation
|
662 | USD | |
us-gaap |
Depreciation
Depreciation
|
51495 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
178020 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1446600 | USD | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
30392 | USD | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
47070 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
241466 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
370089 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-288518 | USD | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
24100 | USD | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
500001 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
200469 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-184937 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1321565 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5545137 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
28298 | USD | |
us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
0 | USD | |
mtnb |
Payments Of Preferred Stock Issuance Costs
PaymentsOfPreferredStockIssuanceCosts
|
4140 | USD | |
mtnb |
Payments Of Preferred Stock Issuance Costs
PaymentsOfPreferredStockIssuanceCosts
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
13498087 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
12148224 | USD | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-5833655 | USD | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
424364 | USD |
CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12572588 | USD |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Matinas BioPharma Holdings, Inc. | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001582554 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
dei |
Trading Symbol
TradingSymbol
|
MTNB | ||
CY2014Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
32167650 | shares |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
15000000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
2378674 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD | |
us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
375000 | USD | |
us-gaap |
Proceeds From Other Equity
ProceedsFromOtherEquity
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
10000 | USD | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD | |
us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
0 | USD | |
us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-4591 | USD | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
20000 | USD | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
0 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
178000 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1447000 | USD | |
CY2013Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
178000 | USD |
CY2014Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
900000 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2380000 | shares | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
100918 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
24082 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.23 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
|||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.94 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0.94 | ||
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3160000 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.94 | |
CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5415000 | shares |
CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.07 | |
CY2014Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
424000 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
94000 | USD |
CY2014Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
66000 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1000 | USD |
CY2013Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
300000 | USD |